Session

IBD (Posters)

TRANSCRIPTOMIC INSIGHT INTO IN VITRO INTERACTION OF ESCHERICHIA COLI WITH IMMUNOGLOBULIN A AS A MODEL OF THE INFLAMMATORY BOWEL DISEASE PATHOGENESIS
TRANSCRIPTOMIC INSIGHT INTO IN VITRO INTERACTION OF ESCHERICHIA COLI WITH IMMUNOGLOBULIN A AS A MODEL OF THE INFLAMMATORY BOWEL DISEASE PATHOGENESIS

IBD (Posters)  et al.

WHICH SECOND-LINE BIOLOGIC AFTER ANTI-TNF FAILURE DURING CROHN'S DISEASE: USTEKINUMAB OR VEDOLIZUMAB, A MULTICENTRE RETROSPECTIVE STUDY
WHICH SECOND-LINE BIOLOGIC AFTER ANTI-TNF FAILURE DURING CROHN'S DISEASE: USTEKINUMAB OR VEDOLIZUMAB, A MULTICENTRE RETROSPECTIVE STUDY

IBD (Posters)  et al.

KNOCKDOWN OF MUC1 AND MUC13 IN INFLAMED INTESTINAL EPITHELIAL CELLS AFFECTS EXPRESSION OF KEY GENES INVOLVED IN INTESTINAL BARRIER HOMEOSTASIS
KNOCKDOWN OF MUC1 AND MUC13 IN INFLAMED INTESTINAL EPITHELIAL CELLS AFFECTS EXPRESSION OF KEY GENES INVOLVED IN INTESTINAL BARRIER HOMEOSTASIS

IBD (Posters)  et al.

IN CONTRAST TO FAECAL CALPROTECTIN (FC), INCREASED FAECAL APHA-1-ANTITRYPSIN (A1AT) EXCRETION IS ASSOCIATED WITH LOW THROUGH LEVELS IN PATIENTS WITH SEVERE ULCERATIVE COLITIS LACKING RESPONSE TO MONOCLONAL ANTIBODY (MAB) THERAPY
IN CONTRAST TO FAECAL CALPROTECTIN (FC), INCREASED FAECAL APHA-1-ANTITRYPSIN (A1AT) EXCRETION IS ASSOCIATED WITH LOW THROUGH LEVELS IN PATIENTS WITH SEVERE ULCERATIVE COLITIS LACKING RESPONSE TO MONOCLONAL ANTIBODY (MAB) THERAPY

IBD (Posters)  et al.

NO ASSOCIATION BETWEEN POST-INFLAMMATORY PSEUDOPOLYPS AND COLORECTAL NEOPLASIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES
NO ASSOCIATION BETWEEN POST-INFLAMMATORY PSEUDOPOLYPS AND COLORECTAL NEOPLASIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES

IBD (Posters)  et al.

EFFICACY, SAFETY AND DRUG SURVIVAL OF THIOGUANINE AS MAINTENANCE TREATMENT FOR INFLAMMATORY BOWEL DISEASE: A MULTI-CENTRE UK STUDY
EFFICACY, SAFETY AND DRUG SURVIVAL OF THIOGUANINE AS MAINTENANCE TREATMENT FOR INFLAMMATORY BOWEL DISEASE: A MULTI-CENTRE UK STUDY

IBD (Posters)  et al.

ABDOMINAL AORTIC CALCIFICATION AS A MARKER OF CHRONIC INFLAMMATION-MEDIATED ATHEROSCLEROSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
ABDOMINAL AORTIC CALCIFICATION AS A MARKER OF CHRONIC INFLAMMATION-MEDIATED ATHEROSCLEROSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

COMBINED MEDICAL AND SURGICAL THERAPY IN COMPLEX PERIANAL CROHN´S DISEASE - EFFICACY AND PREDICTIVE FACTORS FOR THERAPEUTIC FAILURE
COMBINED MEDICAL AND SURGICAL THERAPY IN COMPLEX PERIANAL CROHN´S DISEASE - EFFICACY AND PREDICTIVE FACTORS FOR THERAPEUTIC FAILURE

IBD (Posters)  et al.

NAD IMMUNOMETABOLISM IN NK CELL BIOLOGY DURING INTESTINAL INFLAMMATION
NAD IMMUNOMETABOLISM IN NK CELL BIOLOGY DURING INTESTINAL INFLAMMATION

IBD (Posters)  et al.

PERCEPTION OF THE ROLE OF FOOD AND DIETARY MODIFICATIONS IN THE GENESIS OF SYMPTOMS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND IMPACT ON LIFE STYLE
PERCEPTION OF THE ROLE OF FOOD AND DIETARY MODIFICATIONS IN THE GENESIS OF SYMPTOMS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND IMPACT ON LIFE STYLE

IBD (Posters)  et al.

BODY COMPOSITION ANALYSIS IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE
BODY COMPOSITION ANALYSIS IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

AN INDIRECT COMPARISON BETWEEN USTEKINUMAB AND VEDOLIZUMAB IN CROHN 'S DISEASE: WHICH SECOND-LINE IS BETTER?
AN INDIRECT COMPARISON BETWEEN USTEKINUMAB AND VEDOLIZUMAB IN CROHN 'S DISEASE: WHICH SECOND-LINE IS BETTER?

IBD (Posters)  et al.

VENOUS THROMBOEMBOLISM AFTER RECENT INFLAMMATORY BOWEL DISEASE FLARE: OUTCOMES AND PREDICTORS
VENOUS THROMBOEMBOLISM AFTER RECENT INFLAMMATORY BOWEL DISEASE FLARE: OUTCOMES AND PREDICTORS

IBD (Posters)  et al.

ACUTE SEVERE ULCERATIVE COLITIS: IS THE NEW SCORE PROPOSED BY ACG BETTER TO PREDICT TREATMENT OUTCOMES?
ACUTE SEVERE ULCERATIVE COLITIS: IS THE NEW SCORE PROPOSED BY ACG BETTER TO PREDICT TREATMENT OUTCOMES?

IBD (Posters)  et al.

FIRST-LINE AZATHIOPRINE WITH ALLOPURINOL CO-THERAPY IS A PROMISING LONG-TERM TREATMENT STRATEGY FOR INFLAMMATORY BOWEL DISEASES
FIRST-LINE AZATHIOPRINE WITH ALLOPURINOL CO-THERAPY IS A PROMISING LONG-TERM TREATMENT STRATEGY FOR INFLAMMATORY BOWEL DISEASES

IBD (Posters)  et al.

CLOSTRIDIUM DIFFICILE INFECTION IN IBD PATIENTS HOSPITALIZED IN A TERTIARY CENTER
CLOSTRIDIUM DIFFICILE INFECTION IN IBD PATIENTS HOSPITALIZED IN A TERTIARY CENTER

IBD (Posters)  et al.

DUBLIN SCORE: AN ENDOSCOPIC SCORE TO QUANTIFY INFLAMMATORY ACTIVITY IN ULCERATIVE COLITIS
DUBLIN SCORE: AN ENDOSCOPIC SCORE TO QUANTIFY INFLAMMATORY ACTIVITY IN ULCERATIVE COLITIS

IBD (Posters)  et al.

SYMPTOMATOLOGY AND QUALITY OF LIFE IN INFLAMMATORY BOWEL DISEASE. IS THERE A GOOD CORRELATION BETWEEN THEM AND INFLAMMATORY ACTIVITY?
SYMPTOMATOLOGY AND QUALITY OF LIFE IN INFLAMMATORY BOWEL DISEASE. IS THERE A GOOD CORRELATION BETWEEN THEM AND INFLAMMATORY ACTIVITY?

IBD (Posters)  et al.

NOVEL INSIGHT INTO MECHANISM OF HEALING OF EXPERIMENTAL COLITIS BY INTESTINAL ALKALINE PHOSPHATASE IN OBESE MICE SUBJECTED TO FORCED TREADMILL EXERCISE. INVOLVEMENT OF OXIDATIVE STRESS, PROINFLAMMATORY BIOMARKERS AND INTESTINAL BARRIER PROTEINS
NOVEL INSIGHT INTO MECHANISM OF HEALING OF EXPERIMENTAL COLITIS BY INTESTINAL ALKALINE PHOSPHATASE IN OBESE MICE SUBJECTED TO FORCED TREADMILL EXERCISE. INVOLVEMENT OF OXIDATIVE STRESS, PROINFLAMMATORY BIOMARKERS AND INTESTINAL BARRIER PROTEINS

IBD (Posters)  et al.

PECTIN-COATED AC2-26-LOADED NANOPARTICLES FACILITATE ANASTOMOTIC HEALING IN A MURINE MODEL OF COLONIC SURGERY DURING EXPERIMENTAL COLITS
PECTIN-COATED AC2-26-LOADED NANOPARTICLES FACILITATE ANASTOMOTIC HEALING IN A MURINE MODEL OF COLONIC SURGERY DURING EXPERIMENTAL COLITS

IBD (Posters)  et al.

Item 181 - 200 / 279
1 2 3 4 5 6 7 8 9
10
11 12 13 14